<DOC>
	<DOCNO>NCT01936519</DOCNO>
	<brief_summary>This study examine renal spar impact implement strategy conversion everolimus calcineurin inhibitor base immunosuppressive protocol 3 month post liver transplant</brief_summary>
	<brief_title>Conversion Everolimus From Calcineurin Inhibitor With Mycophenolic Acid : Impact Long Term Renal Function Liver Transplantation .</brief_title>
	<detailed_description>Given increase proportion patient renal failure time transplant , nephrotoxic effect calcineurin inhibitor base immunosuppression associate long term negative survival impact , study proposes examine renal sparing impact conversion everolimus calcineurin inhibitor base immunosuppressive protocol 3 month post liver transplant . The 3 month time point choose allow switch everolimus occur period stable post transplant liver function technical rejection risk lower . The 3 month cut also choose data indicate worsen renal function 4 week , 3 month 1 year post transplant independent risk factor development chronic renal failure end stage renal disease orthotopic liver transplantation . 24 patient randomize 2 arm : Arm A : Conversion Everolimus immunosuppression combine mycophenolic acid ( Myfortic : MPA ) , complete discontinuation Calcineurin inhibitor 3 month post transplant . Arm B : Continuation standard immunosuppressive therapy consist Calcineurin inhibitor associate mycophenolic acid ( Myfortic : MPA ) . Follow : 2 year .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Ability willingness provide write informed consent adhere study regimen . Primary decease donor liver transplant recipient 1870 year age Functioning allograft randomization ( AST , ALT , Total Bilirubin level ≤3 time ULN , AlkP GGT level ≤ 5 time ULN ) . Elevated GGT alone , combination AST , ALT , total bilirubin AlkP within define range exclude patient randomization . Recipients immunosuppressive regimen corticosteroid tacrolimus . Confirmed recipient HCV status Screening ( either serology PCR ) . Abbreviated MDRD eGFR ≥ 30 mL/min/1.73m2 . Local central serum creatinine result within 5 day prior randomization , however sooner Day 25 posttransplantation . Verification least one tacrolimus trough level ≥ 8 ng/mL one week prior randomization . Target trough level 8 ng/mL prior randomization . Patients able take oral medication time randomization . Recipients multiple solid organ islet cell tissue transplant , previously receive organ tissue transplant . Combined liver kidney transplant recipient . Living donor split liver recipient . History malignancy organ system within past 5 year whether evidence local recurrence metastasis , nonmetastatic basal squamous cell carcinoma skin HCC . Hepatocellular carcinoma fulfill Milan criterion ( 1 nodule ≤ 5 cm , 23 nodule &lt; 3 cm , per explant histology recipient liver . Use antibody induction therapy . Patients know hypersensitivity drug use study class , excipients . Recipients ABO incompatible transplant graft . Recipients Hepatitis B surface antigen HIV donor organ . Surgical medical condition , might significantly alter absorption , distribution , metabolism excretion study drug . Women childbearing potential ( WOCBP ) : woman physiologically capable become pregnant , include woman whose career , lifestyle , sexual orientation precludes intercourse male partner woman whose partner sterilize vasectomy mean , UNLESS ( 1 ) meet follow definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/m , ( 2 ) past 6 week surgical bilateral oophorectomy without hysterectomy ( 3 ) use one follow method contraception : surgical sterilization ( e.g. , bilateral tubal ligation , vasectomy ) , hormonal contraception ( implantable , patch , oral ) , copper coat IUD doublebarrier method ( double combination male female condom spermicidal gel , diaphragm , sponge , cervical cap ) . Periodic abstinence ( e.g. , calendar , ovulation , symptothermal , postovulation method ) withdrawal acceptable method contraception . Reliable contraception maintain throughout 3 month study drug discontinuation . History coagulopathy medical condition require longterm anticoagulation would preclude liver biopsy transplantation . ( Low dose aspirin treatment interruption chronic anticoagulant allow ) . Enrollment Exclusion Randomization Severe hypercholesterolemia ( &gt; 350 mg/dL ; &gt; 9 mmol/L ) hypertriglyceridemia ( &gt; 500 mg/dL ; &gt; 8.5 mmol/L ) within 6 month transplantation . Controlled hyperlipidemia acceptable time randomization . Platelet count &lt; 50,000/mm3 randomization . Absolute neutrophil count &lt; 1,000/mm³ white blood cell count &lt; 2,000/mm³ randomization . Patients positive HIV : Negative laboratory result within 6 month randomization acceptable . Clinically significant systemic infection require IV antibiotic randomization . Patients critical care set randomization require life support measure mechanical ventilation , dialysis , vasopressor agent . Patients renal replacement therapy within 7 day prior randomization . Thrombosis major hepatic artery , major hepatic vein , portal vein inferior vena cava . Results obtain within 5 day prior randomization acceptable , however sooner Day 25 posttransplantation . Acute rejection require antibody therapy one steroid sensitive episode acute rejection runin period . Includes patient complete steroid treatment acute rejection within 7 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Everolimus</keyword>
	<keyword>Zortress</keyword>
	<keyword>Renal Function</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>Myfortic</keyword>
	<keyword>Mycophenolic Acid</keyword>
	<keyword>Liver Transplantation</keyword>
</DOC>